RESI Boston, September 26, 2017

Early Stage Therapeutics Investors panel

Ken Phelps, Camargo CEO speaking and moderating the panel of investors.

Important considerations and strategies for Early Stage Biotechs developing new and innovative therapies and looking for investment.

Download This Presentation